The Metabolic Syndrome and Aging

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 2, 2004, Pages 139-142

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GEMFIBROZIL; LEPTIN;

AGING; ANDROPAUSE; BRAIN BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE COURSE; EDITORIAL; GENETIC PREDISPOSITION; HUMAN; HYPERTRIGLYCERIDEMIA; METABOLIC SYNDROME X; MULTIINFARCT DEMENTIA; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 1442282377     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.2.m139     Document Type: Editorial

References (78)

1. Camus JP. Revue du Rhumatisme et des Maladies Osteo-Articulaires. 1966;33:10-14.
2. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Ann Rev Med. 1993;44:121-131.
3. Banks WA, Altmann J, Sapolsky RM, Phillips-Controy JE, Morley JE. Serum leptin levels as a marker for a syndrome X-like condition in wild baboons. J Clin Endocrinol Metab. 2003;88:1234-1240.
4. Perry HM, Morley JE, Horowitz M, Kaiser FE, Miller DK, Wittert G. Body composition and age in African-American and Caucasian women-relationship to plasma leptin levels. Metab Clin Exper. 1997;46:1399-1405.
5. Baumgartner RN, Ross RR, Waters DL, et al. Serum leptin in elderly people: associations with sex hormones, insulin, and adipose tissue volumes. Obesity Res. 1999;7:141-149.
6. Morley JE, Perry HM III, Baumgartner RP, Garry PJ. Leptin, adipose tissue and aging - is there a role for testosterone? J Gerontol Biol Sci. 1999;54A:B108-B109.
7. Sih R, Morley JE, Kaiser FE, Perry HM III, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997;82:1661-1667.
8. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol Med Sci. 2003;58A:618-625.
9. Morley JE, Perry HM. Androgen treatment of male hypogonadism in older males. J Steroid Biochem Molecul Biol. 2003;85:367-373.
10. Mannucci E, Ognibene A, Cremasco F, et al. Plasma adiponectin and hyperglycaemia in diabetic patients. Clin Chem Lab Med. 2003; 41:1131-1135.
11. Krakoff J, Funahashi T, Stehouwe CDA, et al. Inflammatory markers, adiponectin and risk of type 2 diabetes in the Pima Indian. Diabetes Care. 2003;26:1745-1751.
12. Lambert CP, Sullivan DH, Evans WJ. Effects of testosterone replacement and/or resistance training on interleukin-6, tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: A randomized controlled trial. J Gerontol Med Sci. 2003;58A:165-170.
13. Curb JD, Pressel SL, Cutler JA, et al. Ramipril and the development of diabetes. JAMA. 2001;286:1882-1885.
14. Safar M, Thijs L, Staessen JA, Syst-Eur trial: benefits of nitrendipine in the type 2 diabetic hypertensive patients [French]. Arch des Maladies du Coeur et des Vaisseaux. 2003;96:768-771.
15. Adler AI, Stratton IM, Neil HAW, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Brit Med J. 2000;321:412-419.
16. Yasuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BHR, Zinman B. Ramipril and the development of diabetes. JAMA. 2001;286:1882-1885.
17. Fournier A, Ghitu A, Darabont R, et al. Duality of angiotensin II receptors and stroke and cancer risk: is there a link? [French]. Presse Medicale. 1999;28:918-922.
18. Lithell H, Hansson L, Skoog I, et al. The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertension. 2003;21:875-886.
19. Davies MJ, Lawrence IG. Digami (diabetes mellitus, insulin glucose infusion in acute myocardial infarction): theory and practice. Diab Obesity Metab. 2002;4:289-295.
20. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's Disease: review and hypothesis. J Gerontol Med Sci. 2004;59A:178-183.
21. Vellas B, Sinclair A. Commentary. Insulin resistance, obesity, and the risk of neurodegenerative diseases [On Rasgon and Jarvik's "Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis"]. J Gerontol Med Sci. 2004;59A:189.
22. Vischer U, Szanto I, Michel JP. Commentary. The association between insulin resistance, depression and dementia [On Rasgon and Jarvik's "Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis"]. J Gerontol Med Sci. 2004;59A:189-191.
23. Banks WA. Commentary [On Rasgon and Jarvik's "Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis"]. J Gerontol Med Sci. 2004;59A:184-185.
24. Lyketsos CG, Lee H. Commentary. Insulin resistance as a link between affective disorder and Alzheimer's disease: a hypothesis in need of further refinement [On Rasgon and Javik's "Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis"]. J Gerontol Med Sci. 2004;59A:185-187.
25. Newcomer J. Commentary [On Rasgon and Jarvik's "Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis"]. J Gerontol Med Sci. 2004;59A:187-189.
26. Banks WA, Morley JE. Memories are made of this: Recent advances in understanding cognitive impairments and dementia. J Gerontol Med Sci. 2003;58A:314-321.
27. Grossberg GT, Desai AK. Management of Alzheimer's disese. J Gerontol Med Sci. 2003;58A:331-353.
28. Volicer L, Hurley AC. Management of behavioral symptoms in progressive degenerative dementias. J Gerontol Med Sci. 2003;58A: 837-845.
29. Blazer DG. Depression in late life: review and commentary. J Gerontol Med Sci. 2003;58A:249-265.
30. Bruce DG, Casey GP, Grange V, et al. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle cognition in diabetes study. Diabetes Res Clin Pract. 2003;61:59-67.
31. Coker LH, Shumaker SA. Type 2 diabetes mellitus and cognition - an understudied issue in women's health. J Psychosomatic Res. 2003; 54:129-139.
32. Gregg EW, Yaffe K, Cauley JA, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med. 2000;160:174-180.
33. Ottenbacher KJ, Ostir GV, Peek MK, Goodwin JS, Markides KS. Diabetes mellitus as a risk factor for hip fracture in Mexican American older adults. J Gerontol Med Sci. 2002;57A:M648-M653.
34. Nilsson E, Fastbom J, Wahlin A. Cognitive functioning in a population-based sample of very old non-demented and non-depressed persons: the impact of diabetes. Arch Gerontol Ger. 2002;35:93-105.
35. Mooradian AD. Central nervous system complications of diabetes mellitus - a perspective from the blood-brain barrier. Brain Res Rev. 1997;23:210-218.
36. Morley JE, Perry HM, Miller DK. Something about frailty. J Gerontol Med Sci. 2002;57A:M698-M704.
37. Miller DK, Lui LYL, Perry HM, Kaiser FE, Morley JE. Reported and measured physical functioning in older inner-city diabetic African Americans. J Gerontol Med Sci. 1999;54A:M230-M236.
38. Morley JE. An overview of diabetes mellitus in older persons. Clin Geriatr Med. 1999;15:211-224.
39. Rodriguez-Saldana J, Morley JE, et al. Diabetes mellitus in a subgroup of older Mexicans: Prevalence, association with cardiovascular risk factors, functional and cognitive impairment, and mortality. J Am Geriatr Soc. 2002;50:111-116.
40. Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS. Predictors of decline in MMSE scores among older Mexican Americans. J Gerontol Med Sci. 2002;57A:M181-M185.
41. Mooradian AD, Perryman K, Fitten J, Kavonian GD, Morley JE. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. Arch Intern Med. 1988; 148:2369-2372.
42. Flood JF, Mooradian AD, Morley JE. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes. 1990;39: 1391-1398.
43. Ostir GV, Raji MA, Ottenbacher KJ, Markides KS, Goodwin JS. Cognitive function and incidence of stroke in older Mexican Americans. J Gerontol Med Sci. 2003;58A:531-535.
44. Aronow WS, Ahn C, Gutstein H. Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol ≥ 125 mg/dl treated with statins. J Gerontol Med Sci. 2002;57A:M747-M750.
45. Aronow WS, Ahn C. Risk factors for new atherothrombotic brain infarction in older Hispanic men and women. J Gerontol Med Sci. 2002;57A:M61-M63.
46. Hajjar RR. Commentary on "Embracing complexity: a consideration of hypertension in the very old [Commentary]?. J Gerontol Med Sci. 2003;58A:661-662.
47. Goodwin JS. Embracing complexity: a consideration of hypertension in the very old. J Gerontol Med Sci. 2003;58A:653-658.
48. Thomas DR. The struggle to relate epidemiology to real people [Commentary]. J Gerontol Med Sci. 2003;58A:667-668.
49. Aronow WS. What is the appropriate treatment of hypertension in elders? J Gerontol Med Sci. 2002;57A:M483-M486.
50. Flood JF, Morley JE. Differential effects of amylin on memory processing using peripheral and central routes of administration. Peptides. 1992;13:577-580.
51. During MJ, Cao L, Zuzga DS, et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nature Med. 2003;9:1173-1179.
52. Zamboni M, Zoico E, Fantin F, et al. Relation between leptin and the metabolic syndrome in elderly women. J Gerontol Med Sci. In press.
53. Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience. 2002;115:607-615.
54. Helkala EL, Niskanen L, Viinamaki H, Partanen J, Uusitupa M. Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care. 1995;18:681-685.
55. Perlmuter LC, Nathan DM, Goldfinger Sh, Russo PA, Yates J, Larkin M. Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. J Diabetic Complic. 1988;2:210-213.
56. Rogers RL, Meyer JS, McClintic K, Morel KF. Reducing hypertriglyceridemia in elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion. Angiology. 1989;50(4 Pt 1):260-269.
57. Atzmon G, Gabriely I, Greiner W, Davidson D, Schechter C, Barzilai N. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol Med Sci. 2002;57A:M712-M715.
58. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obesity. 2003;27:260-268.
59. McGeer EG, McGeer PL. Inflammatory processes in Alzheimer's disease. Progr Neuro-Psychopharmacol Biol Psychiatry. 2003;27:741-749.
60. Morley JE. Sex hormones and diabetes. Diabetes Rev. 1998;6:6-15.
61. Flood JF, Farr SA, Kaiser FE, Laregina M, Morley JE. Age-related decrease of plasma testosterone in SAMP8 mice-replacement improves age-related impairment of learning and memory. Physiol Behav. 1995;57:669-673.
62. Morley JE, Kumar VB, Bernardo AE, et al. Beta-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 2000;21:1761-1767.
63. Kumar VB, Farr SA, Flood JF, et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 2000;21:1769-1775.
64. Banks WA, Farrr SA, Butt W, Kumar VB, Franko MW, Morley JE. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein. J Pharmacol Exper Ther. 2001;297:1113-1121.
65. Farr SA, Poon HF, Dogrukol-Ak D, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003;84:1173-1183.
66. Rosenthal MJ, Fajardo M, Gilmore S, Morley JE, Naliboff BD. Hospitalization and mortality of diabetes in older adults. A 3-year prospective study. Diabetes Care. 1998;21:231-235.
67. Tafet GE, Bernardini R. Psychoneuroendocrinological links between chronic stress and depression. Progr Neuro-Psychopharmacol Biol Psychiatry. 2003;27:893-903,
68. Fisher A, Morley JE. Antiaging medicine: the good, the bad, and the ugly. J Gerontol Med Sci. 2002;57A:M636-M639.
69. Butler RN, Fossel M, Harman SM, et al. Is there an antiaging medicine? J Gerontol Biol Sci. 2002;57A:B333-B338.
70. Olshansky SJ, Hayflick L, Carnes BA. Position statement on human aging. J Gerontol Biol Sci. 2002;57A:B292-B297.
71. Morley JE, Flaherty JH, Thomas DR. Geriatricians, continuous quality improvement, and improved care for older persons. J Gerontol Med Sci. 2003;58A:809-812.
72. Nebeker JR, Hurdle JF, Bair BD. Medical informatics in geriatrics. J Gerontol Med Sci. 2003;58A:820-825.
73. Tsilimingras D, Rosen AK, Berlowitz DR. patient safety in geriatrics: a call for action. J Gerontol Med Sci. 2003;58:813-819.
74. Hartnell JM, Morley JE, Mooradian AD. Reduction of alkali-induced white blood cell DNA unwinding rate: a potential biomarker of aging. J Gerontol Biol Sci. 1989;44A:B125-B130.
75. Evans WJ. Exercise as the standard of care for elderly people. J Gerontol Med Sci. 2002;57A:M260-M261.
76. Brandon LJ, Gaasch DA, Boyette LW, Lloyd AM. Effects of long-term resistive training on mobility and strength in older adults with diabetes. J Gerontol Med Sci. 2003;58:740-745.
77. Nicklas BJ, Denis KE, Berman DM, Sorkin J, Ryan AS, Goldberg AP. Lifestyle intervention of hypocaloric dieting and walking reduces abdominal obesity and improves coronary heart disease risk factors in obese, postmenopausal, African-American and Caucasian women. J Gerontol Med Sci. 2003;58:181-189.
78. Singh MAF. Exercise comes of age: rationale and recommendations for a geriatric exercise prescription. J Gerontol Med Sci. 2002;57A:M262-M282.